Zentalis Pharmaceuticals, Inc. · NASDAQ:ZNTL
Andrew J. Schwab reported a 6.40% stake in Zentalis Pharmaceuticals, Inc. (Schedule 13G)
Event Dec 18, 2025 · Filed Dec 30, 2025
Andrew J. Schwab reported a 6.40% stake in Zentalis Pharmaceuticals, Inc., 4,838,571 shares, as a passive investor on Dec 18, 2025. Filed Dec 30, 2025 (Schedule 13G).
- Stake
- 6.40%
- Shares
- 4,838,571
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 7 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| 5AM Opportunities II (GP), LLC | 5.20% | 3,947,913 |
| 5AM Opportunities II, L.P. | 5.20% | 3,947,913 |
| 5AM Opportunities (GP), LLC | 1.20% | 890,658 |
| 5AM Opportunities Master Fund L.P. | 1.20% | 890,658 |
| Andrew J. Schwab | 6.40% | 4,838,571 |
| Kush Parmar | 6.40% | 4,838,571 |
| Anna Yaeger | 1.20% | 890,658 |
Source
Related
- Zentalis Pharmaceuticals, Inc.
- 5AM Opportunities II (GP), LLC
- Zentalis Pharmaceuticals, Inc. shareholders
- Form 4 · Bruns Ingmar · Oct 1, 2026
- Form 4 · Walters William Thurman · Aug 19, 2026
- Schedule 13G/A · Walters Group · Aug 19, 2026
- Schedule 13G/A · Barclays PLC · Aug 13, 2026
- Schedule 13G · BlackRock, Inc. · Jul 30, 2026